HomeInsightsPE

Lupin Ltd PE Ratio

Lupin Ltd PE Ratio

stocks purchased

₹ 0.8 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

4.1 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Lupin Ltd

NSE: LUPIN

PE

35.5

Last updated on: Nov 22, 2024

Key Highlights

  • The P/E Ratio of Lupin Ltd is 35.5 as of 22 Nov 12:32 PM .
  • The P/E Ratio of Lupin Ltd changed from 55.2 on March 2019 to 38.5 on March 2024 . This represents a CAGR of -5.83% over 6 years.
  • The Latest Trading Price of Lupin Ltd is ₹ 2059 as of 22 Nov 12:24 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Lupin Ltd

No data available

Company Fundamentals for Lupin Ltd

No data available

Image

Lupin Ltd

NSE: LUPIN

Share Price

₹ 2059.7

16.40 (0.80%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Lupin Ltd

1M

1Y

3Y

5Y

Monitoring Lupin Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20242043.3
19 Nov 20242037.05
18 Nov 20242034.95
14 Nov 20242013.5
13 Nov 20242038.7
12 Nov 20242088.05
11 Nov 20242083.9
08 Nov 20242104.3
07 Nov 20242110.55
06 Nov 20242164.85

SWOT Analysis Of Lupin Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Lupin Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Lupin Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Lupin Ltd3593,214
Sun Pharmaceuticals Industries Ltd384,26,518
Divis Laboratories Ltd861,58,636
Cipla Ltd251,18,365
Torrent Pharmaceuticals Ltd601,05,067
Mankind Pharma Ltd481,02,273

Key Valuation Metric of Lupin Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Lupin Ltd

No data available

* All values are in crore

Historical Revenue of Lupin Ltd

No data available

* All values are in crore

Historical EBITDA of Lupin Ltd

No data available

* All values are in crore

Historical Net Profit of Lupin Ltd

No data available

* All values are in crore

Historical Dividend Payout of Lupin Ltd

No data available

* All values are in %

About Lupin Ltd

  • Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
  • The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. Lupin Ltd was incorporated in the year 1983 with the name Lupin Chemicals Ltd. In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.
  • In the year 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd.

Lupin Ltd News Hub

News

Lupin launches Mirabegron Extended-Release Tablets in US

 Lupin announced the launch of Mirabegron Extended-Release Tablets, 50 mg, in the United S...

Read more

2024-09-04 00:00:00

News

Lupin Ltd soars 2.88%

Lupin Ltd is up for a third straight session in a row. The stock is quoting at Rs 2109.95,...

Read more

2024-08-09 00:00:00

News

Broader mkt rallies; metal shares advance

The benchmark indices continued to trade with strong gains in mid-morning trade. The Nifty...

Read more

2024-08-07 00:00:00

News

Lupin hits 52-week high after Q1 PAT climbs 76% YoY to Rs 801 cr in FY25

Revenue from operations increased 16.28% YoY to Rs 5,514.34 crore during the quarter. Prof...

Read more

2024-08-07 00:00:00

News

Stock Alert: Lupin, Tata Power Company, Bata India, 3M India, Indigo Paints, Gland Pharma

Securities in F&O ban: Aditya Birla Capital, Birlasoft, Chambal Fertilizers, Gujrata Narma...

Read more

2024-08-07 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Lupin Ltd

What is the current PE Ratio of Lupin Ltd?

The Current PE Ratio of Lupin Ltd is 35.49 as on 22 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Nov 2024.

What was the PE Ratio of Lupin Ltd last year?

The PE Ratio of Lupin Ltd was 68.56 last year, now the PE ratio is 35.49, showing a year-on-year growth of -48.2%.

What does the PE Ratio of Lupin Ltd indicate about its stock?

The PE Ratio of Lupin Ltd is 35.49. This ratio indicates that investors are willing to pay 35.49 times the earnings per share for each share of Lupin Ltd.

What is the PE Ratio Growth of Lupin Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Lupin Ltd grew by -48.2% whereas, the EPS ratio grew by 6.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*